scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.ENVRES.2009.08.002 |
P698 | PubMed publication ID | 19740462 |
P50 | author | Alan Ducatman | Q42788938 |
P2093 | author name string | N Kyle Steenland | |
Anoop Shankar | |||
Jessica MacNeil | |||
P433 | issue | 8 | |
P921 | main subject | type 2 diabetes | Q3025883 |
P1104 | number of pages | 7 | |
P304 | page(s) | 997-1003 | |
P577 | publication date | 2009-09-08 | |
P1433 | published in | Environmental Research | Q5381161 |
P1476 | title | A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA). | |
P478 | volume | 109 |
Q41559585 | A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). |
Q28385335 | A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes |
Q28393054 | Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population |
Q33702676 | Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. |
Q51330045 | Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly. |
Q34307019 | Cohort mortality study of workers exposed to perfluorooctanoic acid |
Q27010006 | Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? |
Q37674925 | Early-Life Exposure to Perfluoroalkyl Substances and Childhood Metabolic Function |
Q24633469 | Endocrine disrupting properties of perfluorooctanoic acid |
Q24632957 | Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA) |
Q28385151 | Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review |
Q28383912 | Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant |
Q63349825 | Identification of Per- and Polyfluoroalkyl Substances in the Cape Fear River by High Resolution Mass Spectrometry and Nontargeted Screening |
Q38847297 | Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells |
Q39677606 | Perfluoroalkyl substances and beta cell deficient diabetes |
Q35727717 | Perfluorooctanoic acid exposure for 28 days affects glucose homeostasis and induces insulin hypersensitivity in mice |
Q49644181 | Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial |
Q51246138 | Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women. |
Q101045910 | Plasma metabolites associated with exposure to perfluoroalkyl substances and risk of type 2 diabetes - A nested case-control study |
Q62086877 | Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food |
Q28395550 | Serum Levels of Persistent Organic Pollutants and Insulin Secretion among Children Age 7-9 Years: A Prospective Cohort Study |
Q36939320 | Serum perfluoroalkyl acids concentrations and memory impairment in a large cross-sectional study |
Q40194249 | The Association of Perceived Memory Loss with Osteoarthritis and Related Joint Pain in a Large Appalachian Population |
Search more.